vancomycin has been researched along with cilastatin in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.13) | 18.7374 |
| 1990's | 12 (37.50) | 18.2507 |
| 2000's | 11 (34.38) | 29.6817 |
| 2010's | 6 (18.75) | 24.3611 |
| 2020's | 2 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Bosseray, A; Brion, JP; Hollard, D; Michallet, M; Micoud, M; Nicolini, F; Stahl, JP | 1 |
| Chandrasekar, PH; Levine, DP; Price, S; Rybak, MJ | 1 |
| Bressolle, F; de la Coussaye, JE; Eledjam, JJ; Galtier, M; Kinowski, JM; Wynn, N | 1 |
| Nakagawa, Y; Toyoguchi, T | 1 |
| Maezawa, H; Nakazawa, Y; Saitoh, A; Sakai, O; Sakamoto, M; Saruta, K; Shiba, K; Shindo, N; Yoshida, M; Yoshikawa, K | 1 |
| Nakagawa, Y; Toyoguchi, T; Watanabe, H | 1 |
| Fujita, Y; Fukabori, T; Mizobuchi, K; Nakamura, M; Takashina, R; Takizawa, H | 1 |
| Hosoya, J; Nakagawa, Y; Takahashi, S; Toyoguchi, T; Watanabe, H | 1 |
| Cheadle, WG; Fabian, T; Fry, DE; Gardner, SA; Kesterson, L; Livingston, DH; Malangoni, MA; Polk, HC; Trachtenberg, LS | 1 |
| Hashimoto, Y; Inui, KI; Kokuryo, T; Nakamura, T | 2 |
| Iga, T; Kotaki, H; Kusama, M; Sato, H; Yamada, H; Yamamoto, K | 1 |
| Cristofori, P; Di Modugno, E; Ladel, CH; Lanzoni, A; Marzola, P; Nicolato, E; Sbarbati, A | 1 |
| Ebihara, M; Hosoya, J; Nakagawa, Y; Ojima, F; Shoji, T; Toyoguchi, T | 1 |
| Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
| Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
| Hirai, K; Honda, T; Yamazaki, Y | 1 |
| Bocchi, L; Ceffa, R; Cerretani, D; Fornara, P; Ghisellini, F; Giorgi, G; Neri, L; Ritter, MA | 1 |
| Lartigue, MF; Nordmann, P; Poirel, L; Poyart, C; Réglier-Poupet, H | 1 |
| Bochnia, M; Fraczek, M; Jankowska-Konsur, A; Jaworska, M; Kubacka, M; Mazur, M; Preś, K; Rostkowska-Nadolska, B; Steinmetz-Beck, A | 1 |
| Flores, M; Murillo, J; Stumpf, PG | 1 |
| Batlle, M; de la Cámara, R; de la Rubia, J; Debén, G; Díaz, J; García, R; Jarque, I; Juliá, A; Lahuerta, JJ; López, J; Martino, R; Montesinos, P; Rovira, M; Sanz, MA; Vázquez, L | 1 |
| Higashi, M; Iwasaka, T; Kakimoto, S; Kido, E; Morimoto, S; Morita, T; Someya, K; Sumitani, N; Suzuki, K; Takagishi, H; Yasui, A | 1 |
| Choi, SH; Chung, J; Hong, SB; Jang, HJ; Kim, JW; Koh, Y; Lim, CM | 1 |
| Barthélémy, C; Chai, F; Debaene, B; Décaudin, B; Drouet, M; Lebuffe, G; Odou, P | 1 |
| Álvarez-Sala, LA; Camaño, S; Cercenado, E; Humanes, B; Jado, JC; Lázaro, A; López-Parra, V; Tejedor, A; Torres, AM | 1 |
| Gil, HW; Hwang, HS; Im, DS; Jung, SY; Shin, HJ; Song, HY; Yang, KJ | 1 |
| Branski, LK; Cambiaso-Daniel, J; Capek, KD; De Crescenzo, A; Finnerty, CC; Herndon, DN; Hundeshagen, G; Killion, EA; Kinsky, MP; Mlcak, RP; Norbury, WB; Sljivich, M; Voigt, CD | 1 |
| Alishahi, M; Arastehfar, A; Davani, F; Khorram, M; Sabzi, M; Zomorodian, K | 1 |
| Becerir, T; Tokgün, O; Yuksel, S | 1 |
1 review(s) available for vancomycin and cilastatin
| Article | Year |
|---|---|
Clinical pharmacokinetics during continuous haemofiltration.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Half-Life; Hemofiltration; Humans; Imipenem; Metabolic Clearance Rate; Pharmacokinetics; Protein Binding; Tissue Distribution; Ultrafiltration; Vancomycin | 1994 |
4 trial(s) available for vancomycin and cilastatin
| Article | Year |
|---|---|
[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Ticarcillin; Vancomycin | 1992 |
[Effect of imipenem/cilastatin combined with vancomycin for MRSA infection].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Infections; Urinary Tract Infections; Vancomycin | 1997 |
Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial.
Topics: Aztreonam; Bronchoalveolar Lavage Fluid; Cilastatin; Cross Infection; Drug Therapy, Combination; HLA-DR Antigens; Humans; Imipenem; Pneumonia; Prospective Studies; Respiration, Artificial; Vancomycin; Wounds and Injuries | 1997 |
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.
Topics: Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome; Vancomycin | 2012 |
27 other study(ies) available for vancomycin and cilastatin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
Topics: Animals; Aortic Valve; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Endocarditis, Bacterial; Heart Valve Diseases; Imipenem; Methicillin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 1988 |
[Nephrotoxicity and drug interaction of vancomycin (2)].
Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin | 1996 |
[Two cases of gram-positive sepsis successfully treated with vancomycin in combination with imipenem or cilastatin].
Topics: Adolescent; Cilastatin; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Sepsis; Vancomycin | 1996 |
[Nephrotoxicity and drug interaction of vancomycin].
Topics: Animals; Anti-Bacterial Agents; Cilastatin; Drug Interactions; Drug Therapy, Combination; Imipenem; Kidney; Male; Protease Inhibitors; Rabbits; Thienamycins; Vancomycin | 1996 |
Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits.
Topics: Animals; Anti-Bacterial Agents; Blood Urea Nitrogen; Cilastatin; Creatinine; Dose-Response Relationship, Drug; Drug Interactions; Kidney; Kidney Diseases; Male; Organ Size; Protease Inhibitors; Rabbits; Vancomycin | 1997 |
Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats.
Topics: Animals; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Metabolic Clearance Rate; Rats; Rats, Wistar; Vancomycin | 1998 |
Effect of cilastatin on renal handling of vancomycin in rats.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cilastatin; Half-Life; Kidney; Male; Metabolic Clearance Rate; Protease Inhibitors; Protein Binding; Rats; Rats, Wistar; Vancomycin | 1998 |
Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cilastatin; Cilastatin, Imipenem Drug Combination; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Drug Combinations; Fosfomycin; Glomerular Filtration Rate; Imipenem; Kidney; Male; Nitrogen; Rats; Rats, Wistar; Vancomycin; Weight Gain | 1999 |
Comparison between MRI, microbiology and histology in evaluation of antibiotics in a murine model of thigh infection.
Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; Cilastatin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Evaluation Studies as Topic; Extremities; Histological Techniques; Imipenem; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1999 |
Histamine release induced by antimicrobial agents and effects of antimicrobial agents on vancomycin-induced histamine release from rat peritoneal mast cells.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Cilastatin; Dose-Response Relationship, Drug; Fluconazole; Fosfomycin; Histamine Release; Male; Mast Cells; Miconazole; Peritoneal Cavity; Rats; Rats, Wistar; Vancomycin | 2000 |
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |
Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus aureus.
Topics: Aged; Anti-Bacterial Agents; Bronchi; Bronchitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Influenza, Human; Male; Methicillin; Methicillin Resistance; Respiratory Distress Syndrome; Staphylococcal Infections; Staphylococcus aureus; Trachea; Tracheitis; Vancomycin | 2002 |
The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone-cements: a pharmacokinetic study.
Topics: Acrylic Resins; Biological Availability; Bone Cements; Cilastatin; Drug Delivery Systems; Drug Therapy, Combination; Imipenem; In Vitro Techniques; Solubility; Vancomycin | 2002 |
Ertapenem resistance of Escherichia coli.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluconazole; Gentamicins; Humans; Imipenem; Immunocompromised Host; Middle Aged; Vancomycin | 2007 |
[Sepsis in the sphenoiditis patient].
Topics: Abscess; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Middle Aged; Radiography; Sepsis; Sphenoid Sinus; Sphenoid Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2007 |
Serious postpartum infection due to MRSA in an asymptomatic carrier: case report and review.
Topics: Abscess; Anti-Bacterial Agents; Anticoagulants; Carrier State; Cesarean Section; Cilastatin; Cilastatin, Imipenem Drug Combination; Drainage; Drug Combinations; Female; Heparin; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Pregnancy; Puerperal Infection; Pulmonary Embolism; Radiography; Sepsis; Staphylococcal Infections; Surgical Wound Infection; Thrombophlebitis; Vancomycin; Young Adult | 2008 |
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Disease-Free Survival; Female; Glycopeptides; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Protease Inhibitors; Retrospective Studies; Spain; Stem Cell Transplantation; Survival Rate; Teicoplanin; Transplantation, Autologous; Vancomycin | 2009 |
Peritonitis after gynecological and gastroscopic examinations in a peritoneal dialysis patient.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterococcus; Female; Gastroscopy; Gynecological Examination; Humans; Imipenem; Middle Aged; Peritoneal Dialysis; Peritonitis; Secondary Prevention; Treatment Outcome; Vancomycin | 2010 |
Endothelial Cell Toxicity of Vancomycin Infusion Combined with Other Antibiotics.
Topics: Anti-Bacterial Agents; Cell Death; Cells, Cultured; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Erythromycin; Gentamicins; Human Umbilical Vein Endothelial Cells; Humans; Imipenem; Infusions, Intravenous; Vancomycin | 2015 |
Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cell Survival; Cells, Cultured; Cilastatin; Epithelial Cells; Kidney Tubules, Proximal; Protective Agents; Swine; Vancomycin | 2015 |
Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein.
Topics: Acute Kidney Injury; Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Line; Cell Proliferation; Cilastatin; Cytoprotection; Dose-Response Relationship, Drug; Humans; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Signal Transduction; Time Factors; Vancomycin | 2017 |
Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Creatinine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Incidence; Infections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Texas; Vancomycin | 2017 |
Dual drug delivery of vancomycin and imipenem/cilastatin by coaxial nanofibers for treatment of diabetic foot ulcer infections.
Topics: Anti-Bacterial Agents; Cilastatin; Diabetes Mellitus; Diabetic Foot; Drug Liberation; Escherichia coli; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Nanofibers; Pharmaceutical Preparations; Staphylococcus aureus; Vancomycin | 2021 |
The therapeutic effect of Cilastatin on drug-induced nephrotoxicity: a new perspective.
Topics: Apoptosis; Cell Line; Cell Survival; Cilastatin; Cisplatin; Dose-Response Relationship, Drug; Gentamicins; HEK293 Cells; Hepatitis A Virus Cellular Receptor 1; Humans; Inhibitory Concentration 50; Kidney Diseases; Lipocalin-2; Oxidative Stress; Vancomycin | 2021 |